Chinese regulator grants second approval for lung cancer drug ivonescimab, which has outperformed Merck’s Keytruda in phase ...

Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...

Brensocatib significantly reduced the rate of pulmonary exacerbations and slowed lung function decline in patients with ...

Phase 1 trial of TGW101 in advanced solid tumors is enrolling to assess safety and pharmacokinetics and define the maximum ...

The prior ORCA-V1 trial showed efficacy of cytisinicline for vapers looking to quit. For smokers, the ORCA-2 trial showed ...

The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...

People with high blood pressure that is uncontrolled or poorly treated with most medications may benefit from a new drug that ...

Schizophrenia drug Cobenfy, a key component in Bristol Myers Squibb’s plan to navigate a transition period of major loss of ...

In a Phase 1b/2a trial for lymphoma and cytokine release syndrome, the first group's dose-limiting toxicity observation ...

Practecal, a phase 2b-3 randomised controlled trial which identified a new treatment regimen for drug resistant tuberculosis (TB), cost €33.9m (£28.95n; $38.54m), with an average cost of €61 460 per ...

CsA Ophthalmic Gel is an innovative cyclosporine gel being developed by Zhaoke in China for the treatment of moderate to ...

Cobenfy (xanomeline and trospium chloride) as an adjunctive treatment to atypical antipsychotics demonstrated a 2.0-point ...